Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP)

The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings.
Related Programs

Research and Technology Development

Department Of Defense


Agency: Department of Defense

Office: DARPA - Biological Technologies Office

Estimated Funding: $493,827


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Beta.SAM Contract Opportunities

Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.

See the Eligibility Information section of the BAA for more information.

Full Opportunity Web Address:
https://sam.gov/opp/36db79ac97b0496399f472d5f2d5dd5a/view

Contact:


Agency Email Description:
renee_robichaud@fws.gov

Agency Email:


Date Posted:
2021-05-28

Application Due Date:


Archive Date:
2021-09-09


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


Social Innovation Fund Pay for Success | Entrepreneurial Training and Technical Assistance Women and Girls Program | Program of Protection and Advocacy of Individual Rights | Charter Schools | Staffing for Adequate Fire and Emergency Response (SAFER) |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders